Pharma & Biotech News #PharmaBuzz

European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

Weekly News Recap #Phispers

FDA seeks more safety data from Lilly on obesity drug Foundayo; Novo partners OpenAI to speed up drug development

This week’s Phispers brings you news on how artificial intelligence (AI) is taking centerstage in the world of pharmaceut...

Impressions : 1969

Neurocrine buys Soleno for US$ 2.9 bn; Novo says Wegovy pill outperforms Lilly's Foundayo in cross-trial comparison

In Phispers this week, Neurocrine Biosciences announced the acquisition of rare-disease drugmaker Soleno Therapeutics for US$ ...

Impressions : 1271

Lilly in US$ 7.8 bn deal to acquire Centessa for its sleep disorder pipeline; bags FDA nod for obesity med orforglipron

In Phispers this week, the US Food and Drug Administration (FDA) approved Eli Lilly’s Foundayo (orforglipron), a once-dai...

Impressions : 1118

Merck buys Terns Pharma for US$ 6.7 bn to boost cancer portfolio; Novartis acquires Synnovation unit for up to US$ 3bn

This week’s Phispers is packed with news of drug approvals and M&As. Merck is preparing for its future post-Keytruda pate...

Impressions : 819

Only few entries up to this point, click to access all

Quality Compliance Alerts #Warning!

All News #Library

Generics

Biotech

APIs

Quality

Sciences

Rare Diseases

Others

NEWS

DRUGS & DEVELOPMENTS

MARKET INTEL by PharmaCompass

FDA seeks more safety data from Lilly on obesity drug Foundayo; Novo partners OpenAI to speed up drug development

Neurocrine buys Soleno for US$ 2.9 bn; Novo says Wegovy pill outperforms Lilly's Foundayo in cross-trial comparison

Lilly in US$ 7.8 bn deal to acquire Centessa for its sleep disorder pipeline; bags FDA nod for obesity med orforglipron

Merck buys Terns Pharma for US$ 6.7 bn to boost cancer portfolio; Novartis acquires Synnovation unit for up to US$ 3bn

Mankind's Generics Brimonidine Tartrate Receives Approval in US

Hetero's Generics Ibrutinib Receives Tentative Approval in US

Aspiro's Generics Sodium Bicarbonate Receives Approval in US

Alembic's Generics Methotrexate Na Receives Approval in US

Msn's Generics Glycerol Phenylbutyrate Receives Approval in US

Edenbridge's Generics Atropine Sulfate Receives Approval in US

Teva's Generics Glycerol Phenylbutyrate Receives Approval in US

Aurobindo's Generics Dextromethorphan Receives Approval in US

Qilu's Generics Sugammadex Receives Tentative Approval in US

Baxter's Generics Dexmedetomidine HCl Receives Approval in US

Enforcement Report - Week of April 15, 2026

Pure Indulgence Aesthetics' Receives FDA Warning Letter

Enforcement Report - Week of April 8, 2026

Blaine Labs Issues Voluntary Nationwide Recall of Wound Care Gel

Ehsan Sadri's Receives FDA Warning Letter

Huons Co. is on FDA Import Alert List

Enforcement Report - Week of April 1, 2026

IDO PHARM is on FDA Import Alert List

Sun Pharma Fails EDQM Inspection

Eugia Pharma Fails EDQM Inspection

Pasithea Therapeutics Announces Grant of RPDD by FDA to PAS-004

FDA Draft Guidance sets Impurity Controls for Most Antibiotics

Neuland Lab elevates Saradhi Bolli to Global Head of CDMO BD

Rusan Pharma secure Japan PMDA GMP approval for API, FDF facility

Trump orders FDA to fast-track reviews of psychedelic drugs

Biogen inks $850M deal with TJ for China rights antibody

Eli to buy Boston's Kelonia for up to $7 Billion in Cancer Push

Astra's Tozorakimab Delivers Reduction in Lung Disease Flare-ups

Boehringer launches AI centre for pharma research in London

UICC report flags air pollution as major multi-cancer risk

Trump set to restrictions on psychedelic drug used to treat PTSD

Aurobindo Pharma Gets USFDA Nod For Glycerol Phenylbutyrate

Dr Reddy's Gets Nod To Roll Out Generic Oral Semaglutide Drug

MSN Labs Launches SEMABEST Semaglutide in India After CDSCO Nod

Pangea Pharma Launches Sdamlo, First FDA-Approved Amlodipine

Orbicular, Gland Pharma, Apotex Obtain US FDA Approval

Amneal Launches First Two Respiratory Metered-Dose Inhalers in US

Apotex Secures FDA Approval For Generic Infuvite Adult

FDA signs off on generics for AstraZeneca's Farxiga

ANI Pharma Launches Carbamazepine Extended-Release Capsules

Trump orders FDA to fast-track reviews of psychedelic drugs

Biogen inks $850M deal with TJ for China rights antibody

Eli to buy Boston's Kelonia for up to $7 Billion in Cancer Push

Astra's Tozorakimab Delivers Reduction in Lung Disease Flare-ups

Boehringer launches AI centre for pharma research in London

CPC Biotech Launches Versatile AseptiQuik G Connector

With global goals, Zai Lab offers China reality check

Sanofi's new COVID shot tops Moderna's mNexspike in safety trial

Nektar's long-term Mid-Stage Alopecia Data fuel Phase 3 plans

Nektar Therapeutics Announces Proposed Public Offering

Rusan Pharma secure Japan PMDA GMP approval for API, FDF facility

FDA Accepts NorthStar's DMF for No-Carrier-Added AC-225

SQ Innovation And FIS Strike Supply Deal For Furosemide API

Integrating R&D and Manufacturing in API Development

Iran Conflict: Pharma Chains Face Months-Long Recovery

Government Boosts Pharma Feedstock Amid West Asia Tensions

Rajesh Agrawal Urges Pharma to Cut Import Dependence

HRV Pharma, Shodhana Partner For Next-Gen API Development

Pharmexcil Urges Chemical Allocation To Prevent Drug Shortages

Raigad Mega Bulk Drug Park To Boost Maharashtra Pharma

Drug regulator transfers 95 officials in mass reshuffle

Theramex exits self-regulatory body after compliance failures

Eli Lilly flags counterfeit Mounjaro seizure in Gurugram

FDA Warns Firm For Inappropriate Use Of AI In Drug Manufacturing

More transparency, evidence needed for accelerated nods: ICER

Teva, Viatris launch separate recalls in the US

FDA Cracks Down on Drug Ads with 3 Untitled Letters

Pfizer Rebuked By FDA For Misleading Adcetris Ads On Facebook

Indoco Remedies & Panacea Biotec: Key Briefs

CS Analytical Names Roark as Director of Scientific Affairs

UICC report flags air pollution as major multi-cancer risk

Millions Suffering Needlessly With Curable Hepatitis C

AbbVie launches 'PSO Done' Psoriasis Campaign